Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Lorazepam Use and Acute Toxicity in the Aged
NCT00044642Phase 4Completed
- Sponsor
- Nathan S. Kline Institute for Psychiatric Research
- Start
- Dec 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lorazepam in generalized anxiety disorder (GAD), sponsored by Nathan S. Kline Institute for Psychiatric Research. Started Dec 2000; status: completed.
02
Drugs
lorazepam
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00044642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044642.